TB-500 (Thymosin Beta-4)

What it is (in plain language)
- If BPC-157 is the master builder, TB-500 is the logistics system that gets the repair cells to where they are needed. It promotes cell migration and tissue differentiation, and is especially effective in tissue flexibility, reducing inflammation in the joints and capillary growth. It travels throughout the body to find damaged areas.

Why do you appear online so much
- It is almost always mentioned together with BPC-157 as the 'Ultimate Recovery Stack'. It is highly valued by horsemen (historical veterinary use) and athletes for preventing the formation of adhesions and hard scar tissue, maintaining the elasticity of tendons after serious injuries.

How it is framed today (pragmatic view)
- 1) Evidence: Strong data in cardiac regeneration and dermal wound healing. 2) Purpose: Systemic recovery, joint health and cardiac/ocular tissue repair. 3) Risk: Like other growth factors, monitoring of systemic signs is prudent during prolonged use.

How to use this form
- See the protocols section to understand the difference between the 'loading' and 'maintenance' phase typical of this compound.

- Quick profile (curated by Subject 157)
- Class: Repair
- Status: Verified
- Use case: Repair
- Route: Injectable
- Tags: Injectable|Muscle|Recovery
- Half-life: ~2 Hours
- Start: Variable
- Duration: ~7-10 Days (Effect)

- Mechanism (high level)
Synthetic fragment (LKKTETQ) or complete sequence of Thymosin Beta-4. Acts by sequestering G-Actin, promoting cell migration (repair) and reducing fibrosis/scarring. Potent anti-inflammatory.

- Evidence (what the literature covers)
RESEARCH RANGE (Non-prescriptive):
Common protocols use 2mg to 5mg per week (loading phase).
Level of Evidence: B.

- Safety and harm-reduction (non-prescriptive)
Risks: Tiredness or temporary lethargy.
Interactions: Unknown.

- References (anchors)
- Philp, D. (2004) - Thymosin beta4 promotes wound repair - https://doi.org/10.1016/j.mad.2003.11.005 | PubMed:15062953
- Crockford, D. (2012) - Thymosin beta-4 clinical potential - https://doi.org/10.1517/14712598.2012.634793 | PubMed:22074291

Note: Educational/research content. Does not constitute medical advice, diagnosis or prescription.